loading page

Ondansetron in pregnancy revisited: Assessment and pregnancy labelling by the European Medicines Agency (EMA) & Pharmacovigilance Risk Assessment Committee (PRAC).
  • Per Damkier
Per Damkier
University of Southern Denmark Department of Clinical Research

Corresponding Author:[email protected]

Author Profile
18 Mar 2020Submitted to BJOG: An International Journal of Obstetrics and Gynaecology
19 Mar 2020Assigned to Editor
19 Mar 2020Submission Checks Completed
27 Mar 2020Reviewer(s) Assigned
13 Apr 2020Review(s) Completed, Editorial Evaluation Pending
28 Apr 2020Editorial Decision: Revise Major